| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Butyrate | Atopic Dermatitis | 2 | PM | 38159175 | 📋 | Sodium Butyrate Ameliorates Atopic Dermatitis-Induced Inflammation by Inhibiting HDAC3-Mediated STAT1 and NF-κB Pathway |
| Butyrate | Atopic Dermatitis | 1 | PM | 37261337 | 📋 | Butyrate inhibits Staphylococcus aureus-aggravated dermal IL-33 expression and skin inflammation through histone deacetylase inhibition |
| Butyrate | Autism Spectrum Disorder | 1 | PM | 36274465 | 📋 | Maternal treatment with sodium butyrate reduces the development of autism-like traits in mice offspring |
| Butyrate | Chronic Inflammation | 2 | PM | 37375664 | 📋 | Butyrate Protects Barrier Integrity and Suppresses Immune Activation in a Caco-2/PBMC Co-Culture Model While HDAC Inhibition Mimics Butyrate in Restoring Cytokine-Induced Barrier Disruption |
| Butyrate | Chronic Inflammation | 1 | PM | 36792800 | 📋 | Butyrate limits human natural killer cell effector function |
| Butyrate | Fibromyalgia | 1 | PM | 36989891 | 📋 | The immunomodulatory effects of ethosuximide and sodium butyrate on experimentally induced fibromyalgia: The interaction between IL-4, synaptophysin, and TGF-β1/NF-κB signaling |
| Butyrate | Myasthenia Gravis | 1 | PM | 37924056 | 📋 | Sodium butyrate alleviates R97-116 peptide-induced myasthenia gravis in mice by improving the gut microbiota and modulating immune response |
| Butyrate | Ulcerative Colitis | 4 | PM | 38061600 | 📋 | Butyrate ameliorated ferroptosis in ulcerative colitis through modulating Nrf2/GPX4 signal pathway and improving intestinal barrier |
| Butyrate | Ulcerative Colitis | 3 | PM | 37665564 | 📋 | Sodium Butyrate Protects Against Intestinal Oxidative Damage and Neuroinflammation in the Prefrontal Cortex of Ulcerative Colitis Mice Model |
| Butyrate | Ulcerative Colitis | 2 | PM | 36389141 | 📋 | Sodium butyrate treatment and fecal microbiota transplantation provide relief from ulcerative colitis-induced prostate enlargement |
| Butyrate | Ulcerative Colitis | 1 | PM | 35194640 | 📋 | Gut microbiota-derived butyrate regulates gut mucus barrier repair by activating the macrophage/WNT/ERK signaling pathway |
